Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA: 600222)
China flag China · Delayed Price · Currency is CNY
5.18
-0.10 (-1.89%)
Dec 25, 2024, 3:00 PM CST

Henan Taloph Pharmaceutical Stock Co.,Ltd Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
2,8573,4293,5445,0562,7352,505
Upgrade
Market Cap Growth
-6.34%-3.25%-29.90%84.84%9.21%28.37%
Upgrade
Enterprise Value
3,4893,9653,8145,7423,2103,201
Upgrade
Last Close Price
5.156.096.338.914.964.52
Upgrade
PE Ratio
32.1078.72-843.3393.5556.39
Upgrade
PS Ratio
1.461.661.813.151.931.91
Upgrade
PB Ratio
1.822.112.202.841.791.75
Upgrade
P/TBV Ratio
2.382.772.873.832.472.44
Upgrade
P/FCF Ratio
-5673.81-83.463529.88-
Upgrade
P/OCF Ratio
-78.40-50.7437.2560.32
Upgrade
EV/Sales Ratio
1.771.921.953.582.272.44
Upgrade
EV/EBITDA Ratio
19.7531.2796.8633.9127.2920.66
Upgrade
EV/EBIT Ratio
32.7752.21-45.8142.1127.41
Upgrade
EV/FCF Ratio
-149.866560.69-94.774142.80-
Upgrade
Debt / Equity Ratio
0.610.480.410.690.870.80
Upgrade
Debt / EBITDA Ratio
5.555.4412.086.7111.267.39
Upgrade
Debt / FCF Ratio
-1290.72-20.221709.07-
Upgrade
Asset Turnover
0.560.580.530.450.450.45
Upgrade
Inventory Turnover
2.913.333.593.143.232.79
Upgrade
Quick Ratio
0.750.880.850.890.971.45
Upgrade
Current Ratio
1.071.211.181.181.251.83
Upgrade
Return on Equity (ROE)
6.06%2.77%-4.47%0.41%1.87%3.02%
Upgrade
Return on Assets (ROA)
1.88%1.32%-0.13%2.18%1.51%2.53%
Upgrade
Return on Capital (ROIC)
2.75%2.03%-0.19%2.67%1.76%2.83%
Upgrade
Earnings Yield
3.11%1.27%-2.04%0.12%1.07%1.77%
Upgrade
FCF Yield
-0.81%0.02%-5.39%1.20%0.03%-2.64%
Upgrade
Dividend Yield
0.35%0.30%-0.11%0.32%-
Upgrade
Payout Ratio
79.43%115.18%-1410.34%223.89%136.30%
Upgrade
Buyback Yield / Dilution
1.13%-0.07%-0.36%-2.52%1.68%3.16%
Upgrade
Total Shareholder Return
1.48%0.22%-0.36%-2.40%2.00%3.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.